Prostate cancer Board decisions

The Veteran's claim for a compensable rating for erectile dysfunction associated with chronic prostatitis was denied. The service connection for depressive disorder as secondary to multiple service-connected disabilities, including prostate cancer and ED, is granted.,TDIU from March 1, 2023, is granted, but TDIU from December 22, 2021 to March 1, 2023, was denied. The discontinuance of the 100% rating for prostate cancer as of March 1, 2023, and a rating of over 60% for prostate cancer residuals with status post prostatectomy are also addressed.

The Board denied the Veteran's claim for service connection for prostate cancer, finding that there is no causal relationship between his exposure to contaminated water at Camp Lejeune and his prostate cancer. The evidence did not support a nexus between the two.

The Board denied service connection for prostate cancer and a resulting prostatectomy, attributing the denial to insufficient evidence linking the conditions to active military service or exposure to contaminated water at Camp Lejeune.

The Board dismissed the appeals regarding the reduction of the rating for prostate cancer with urinary incontinence and the discontinuance of SMC based on Statutory Housebound.

The Board has remanded the claims for service connection for coronary artery disease, prostate cancer, and metastatic prostate cancer to the bone due to additional development being needed. Specifically, verification of in-service exposure to herbicides is required, and a medical opinion on the relationship between in-service toxic exposures and the Veteran's current conditions is needed.

The Veteran withdrew his appeal for an earlier effective date for service connection of prostate cancer.

The Veteran's prostate cancer is presumed related to his exposure to herbicide agents while serving at Clark AFB, and the Board has granted service connection for this condition.

The Veteran's service connection claim for prostate cancer residuals due to herbicide exposure is denied because there was no credible evidence of in-service exposure and the condition did not manifest within one year after separation from service.

The Veteran's anxiety disorder with depressive disorder and prostate cancer have been granted increased ratings, effective November 8, 2023. The Veteran also received earlier effective dates for service connection of hypertension and Dependents' Educational Assistance.

The Veteran's appeals for an increased rating in excess of 60 percent for prostate cancer and special monthly compensation based on housebound criteria have been dismissed due to his withdrawal of the appeal.

The Board has decided to remand the claim of service connection for erectile dysfunction as secondary to prostate cancer due to a lack of sufficient medical evidence addressing all theories of entitlement.

The Veteran's claim for an effective date prior to January 22, 2018 for service connection of prostate cancer is denied as the evidence does not meet the criteria for an earlier effective date.

The Veteran's acquired psychiatric conditions, DJD of the lumbar spine, and DJD of the cervical spine are granted service connection. Service connection for prostate cancer is also granted due to exposure to herbicide agents including Agent Orange during his Vietnam War service.

The Board has remanded the issues of service connection for prostate cancer and bladder cancer due to potential outstanding VA or private medical records, as well as a need for an opinion regarding whether these conditions are related to exposure at Camp Lejeune.

The Veteran's appeal for increased ratings and service connection for secondary disabilities related to his prostate cancer residuals is being remanded due to the need for additional development.

The Board has granted service connection for prostate cancer and myasthenia gravis, finding that the Veteran's conditions are at least as likely as not related to his military service.

The Board has found that the development conducted does not comply with prior remand directives and requires additional VA medical opinions to address the Veteran's reports of visible burns from radiation treatment, as well as his pre-existing conditions. The case is therefore being returned for further action.

The Veteran's claims for service connection for prostate cancer, erectile dysfunction (secondary to prostate cancer), and residuals of right kidney removal (claimed as renal cell carcinoma) are all granted. The claim for the right kidney disorder is remanded due to a failure to consider in-service Agent Orange exposure.

The Veteran's service-connected disabilities rendered him unable to obtain or sustain substantially gainful employment, and TDIU is granted on a schedular basis. Prior to October 28, 2021, the Veteran was not in receipt of a 100% rating for his prostate cancer, so entitlement to a TDIU rating on an extraschedular basis is remanded.

The Board has remanded the cases for further development and consideration, including obtaining an opinion regarding the Veteran's side effects from his Lupron medication and developing a claim for TDIU.